Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register-Reference-Cited by-同舟云学术

Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register

Published:2011-06-15 Issue:10 Volume:54 Page:2544-2551
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Gudbjörnsdottir S., ,Eliasson B.,Eeg-Olofsson K.,Zethelius B.,Cederholm J.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-011-2218-1.pdf

Reference36 articles.

1. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection. JAMA 285:2486–2497

2. Turner RC, Millns H, Holman RR, for the United Kingdom Prospective Diabetes Study Group et al (1998) Risk factors for coronary artery disease in noninsulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316:823–828

3. D’Agostino R, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care. The Framingham Heart Study. Circulation 117:743–753

4. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR, on behalf of the United Kingdom Prospective Diabetes Study (UKPDS) Group (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clinical Science 101:671–679

5. Holman RR, Coleman RL, Shine BSF, Stevens RJ (2005) Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. Diabetes Care 28:1796–1797

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65;Scientific Reports;2023-10-12

2. Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?;Diabetologia;2022-07-29

3. Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME Trial;The Journal of Clinical Endocrinology & Metabolism;2020-06-02

4. Total/high density lipoprotein cholesterol and cardiovascular disease (re)hospitalization nadir in type 2 diabetes;Journal of Lipid Research;2018-09

5. Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta‐Analysis;Journal of the American Heart Association;2018-06-05